Anti-perilipin-1 autoantibodies in autoimmune Addison's disease and related endocrine disorders

被引:0
作者
Rahman, Muhammad O. [1 ]
Sulen, Andre [1 ]
Breivik, Lars [1 ,2 ]
Appel, Silke [3 ]
Anderson, Mark S. [4 ]
Oftedal, Bergithe E. [1 ,2 ]
Wolff, Anette S. B. [1 ,2 ]
Husebye, Eystein S. [1 ,2 ]
机构
[1] Univ Bergen, Dept Clin Sci, Endocrine Med Grp, Bergen, Norway
[2] Haukeland Hosp, Dept Med, Bergen, Norway
[3] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway
[4] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA USA
关键词
Addison's disease; Idiopathic Addison's disease; Autoimmune polyendocrine syndromes; Graves' disease; Type; 1; diabetes; Sj & ouml; gren's syndrome; ACQUIRED LIPODYSTROPHY; PERILIPIN; DIAGNOSIS; DEFINE; TISSUE;
D O I
10.1080/08916934.2025.2461703
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune-mediated lipodystrophy syndromes are rare autoimmune disorders characterized by complete or partial destruction of adipocytes in the body. Recently, autoantibodies against perilipin-1 (PLIN1-autoAbs) have been linked to lipodystrophy. Since various perilipins are expressed in the adrenal cortex and ovaries, we asked whether PLIN1-autoAbs were present in patients with adrenal dysfunction and other autoimmune endocrinopathies. Using a sensitive radiobinding immune assay we analyzed anti-PLIN1-autoAbs in 521 patients with endocrinopathies including Sj & ouml;gren's syndrome. We identified 22 (4.2%) PLIN1-autoAbs positive patients, of whom 15% had autoimmune polyendocrine syndrome type 1 (4/27), 4% autoimmune Addison's disease and/or autoimmune polyendocrine syndrome type 2 (11/274), 8% type 1 diabetes patients (4/53), and 2% Sj & ouml;gren's syndrome patients (1/50). However, none of them had known lipodystrophy. In conclusion, PLIN1-autoAbs are found in subgroups of autoimmune endocrinopathies and indicate autoimmunity against adipose tissue, but their pathogenic role if any, remains to be defined. Investigating their role in disease progression and their potential as therapeutic targets could pave the way for novel interventions in autoimmune endocrine diseases.
引用
收藏
页数:8
相关论文
共 25 条
  • [1] Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
    Bingham, April
    Mamyrova, Gulnara
    Rother, Kristina I.
    Oral, Efif
    Cochran, Elaine
    Premkumar, Ahalya
    Kleiner, David
    James-Newton, Laura
    Targoff, Ira N.
    Pandey, Janardan P.
    Carrick, Danielle Mercatante
    Sebring, Nancy
    O'Hanlon, Terrance P.
    Ruiz-Hidalgo, Maria
    Turner, Maria
    Gordon, Leslie B.
    Laborda, Jorge
    Bauer, Steven R.
    Blackshear, Perry J.
    Imundo, Lisa
    Miller, Frederick W.
    Rider, Lisa G.
    [J]. MEDICINE, 2008, 87 (02) : 70 - 86
  • [2] The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
    Brown, Rebecca J.
    Araujo-Vilar, David
    Cheung, Pik To
    Dunger, David
    Garg, Abhimanyu
    Jack, Michelle
    Mungai, Lucy
    Oral, Elif A.
    Patni, Nivedita
    Rother, Kristina I.
    von Schnurbein, Julia
    Sorkina, Ekaterina
    Stanley, Takara
    Vigouroux, Corinne
    Wabitsch, Martin
    Williams, Rachel
    Yorifuji, Tohru
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (12) : 4500 - 4511
  • [3] Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy
    Corvillo, Fernando
    Abel, Brent S.
    Lopez-Lera, Alberto
    Ceccarini, Giovanni
    Magno, Silvia
    Santini, Ferruccio
    Araujo-Vilar, David
    Brown, Rebecca J.
    Nozal, Pilar
    Lopez-Trascasa, Margarita
    [J]. DIABETES, 2023, 72 (01) : 71 - 84
  • [4] Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy
    Corvillo, Fernando
    Aparicio, Veronica
    Lopez-Lera, Alberto
    Garrido, Sofia
    Araujo-Vilar, David
    de Miguel, Maria P.
    Lopez-Trascasa, Margarita
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans
    Desgrouas, Camille
    Thalheim, Tabea
    Cerino, Mathieu
    Badens, Catherine
    Bonello-Palot, Nathalie
    [J]. CARDIOVASCULAR RESEARCH, 2024, 120 (03) : 237 - 248
  • [6] Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma
    Falcao, Camila Kruschewsky
    Simoes Cabral, Marina Campos
    Mota, Jose Mauricio
    Arbache, Samia Trigo
    Costa-Riquetto, Aline Dantas
    Borges Muniz, David Queiroz
    Cury-Martins, Jade
    Almeida, Madson Q.
    Kaczemorska, Priscilla Cukier
    Nery, Marcia
    Teles, Milena Gurgel
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08) : 3245 - 3248
  • [7] Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy
    Gandotra, Sheetal
    Le Dour, Caroline
    Bottomley, William
    Cervera, Pascale
    Giral, Philippe
    Reznik, Yves
    Charpentier, Guillaume
    Auclair, Martine
    Delepine, Marc
    Barroso, Ines
    Semple, Robert K.
    Lathrop, Mark
    Lascols, Olivier
    Capeau, Jacqueline
    O'Rahilly, Stephen
    Magre, Jocelyne
    Savage, David B.
    Vigouroux, Corinne
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (08) : 740 - 748
  • [8] Acquired lipodystrophy associated with immune checkpoint inhibitors
    Gnanendran, Subashini S.
    Miller, James A.
    Archer, Christine A.
    Jain, Swaranjali, V
    Hwang, Shelley J. E.
    Peters, Geoffrey
    Miller, Andrew
    [J]. MELANOMA RESEARCH, 2020, 30 (06) : 599 - 602
  • [9] GREENBERG AS, 1991, J BIOL CHEM, V266, P11341
  • [10] Acquired generalized lipodystrophy under immune checkpoint inhibition
    Haddad, N.
    Vidal-Trecan, T.
    Baroudjian, B.
    Zagdanski, A. -M.
    Arangalage, D.
    Battistella, M.
    Gautier, J. -F.
    Lebbe, C.
    Delyon, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) : 477 - 480